Annual International Meeting of the Association for Pharmacoeconomics and Outcomes Research. Philadelphia, Pennsylvania (USA), 1996/05/12.
Four years ago it became obvious within the US Department of Defense (DOD) that expenditures for pharmaceuticals and health care were escalating beyond control.
Realizing this upward pressure on costs was one of the major trends jeopardizing the military health care system, which cares for 8 million-plus beneficiaries, the DOD began using pharmacoeconomics to manage pharmacy expenditures.
The DOD has several competing goals :
to reduce pharmaceutical expenditures within the context of an open formulary while maintaining optimum patient care ;
provide practitioners, pharmacists, and administrators with the information they need to make cost-effective choices in pharmacotherapy ;
and provide for a consistent and equitable pharmacy benefit throughout the DOD based on cost-effective recommendations.
Currently used methods for pharmacoeconomics did not meet the DOD's needs, so it turned to applied pharmacoeconomics.
This paper discusses the use of applied pharmacoeconomics as it pertains to the DOD.
Mots-clés Pascal : Médicament, Analyse coût efficacité, Contrôle coût, Economie santé, Evaluation, Efficacité traitement, Modélisation, Modèle mathématique, Homme, Secteur public, Soin pharmaceutique
Mots-clés Pascal anglais : Drug, Cost efficiency analysis, Cost control, Health economy, Evaluation, Treatment efficiency, Modeling, Mathematical model, Human, Public sector, Pharmaceutical care
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0228518
Code Inist : 002B30A04B. Création : 11/06/1997.